Imperial College London

ProfessorRobinShattock

Faculty of MedicineDepartment of Infectious Disease

Chair in Mucosal Infection and Immunity
 
 
 
//

Contact

 

+44 (0)20 7594 5206r.shattock

 
 
//

Location

 

453Wright Fleming WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Fletcher:2016:10.1089/aid.2015.0315,
author = {Fletcher, P and Herrera, C and Armanasco, N and Nuttall, J and Shattock, RJ},
doi = {10.1089/aid.2015.0315},
journal = {AIDS Research and Human Retroviruses},
pages = {334--338},
title = {Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues},
url = {http://dx.doi.org/10.1089/aid.2015.0315},
volume = {32},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - The potential of maraviroc (MVC), a small-molecule CCR5 antagonist, as a candidate to prevent HIV-1 sexual transmission by oral or topical dosing has not yet been completely established. Using relevant cellular and mucosal tissue explant models, we show partial antiviral activity of MVC when tested in multiple preclinical dosing strategies.
AU - Fletcher,P
AU - Herrera,C
AU - Armanasco,N
AU - Nuttall,J
AU - Shattock,RJ
DO - 10.1089/aid.2015.0315
EP - 338
PY - 2016///
SN - 0889-2229
SP - 334
TI - Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues
T2 - AIDS Research and Human Retroviruses
UR - http://dx.doi.org/10.1089/aid.2015.0315
VL - 32
ER -